sglt2 semaglutide Complementary Yet Distinct Roles of GLP-1 Receptor Agonists and Inhibitors in Cardiovascular Risk Reduction sglt-2_inhibitors [TUSOM | Pharmwiki]

In agreement with expectations, the first outcome trial of a GLP-1RA, the ELIXA trial of the short-acting lixisenatide, an exendin-4 derivative with properties almost identical to those of exendin-4 or exenatide (stable, full agonists of the GLP-1 receptor), showed no increased cardiovascular risk in a patient group with severely increased CVD risk

Using lower-than-approved doses for weight loss or other benefits is off-label

In clinical trials, only about 11% of participants stopped treatment due to side effects at the highest dose level

However, information related to pregnancy appears in Section 8.1 & 8.3 of the prescribing information for both Ozempic and Wegovy." Novo Nordisk has also created a Wegovy Pregnancy Registry to collect health data from women who take the GLP-1 medications during pregnancy

It is crucial for optimal calorie burning, increased energy, and strong bones (Academy of Nutrition and Dietetics 2021)